SHARON BENZENO Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for SHARON BENZENO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SHARON BENZENO. SHARON BENZENO is Chief Business Development Off in Adaptive Biotechnologies Corp ($ADPT) and SVP, Drug Discovery in Adaptive Biotechnologies Corp ($ADPT).
Latest Insider Trading Transactions of SHARON BENZENO
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 08 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | A | 43.68 | 57,234 | 2,499,981 | 57,234 | |
Mar 08 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Grant | A | 0.00 | 22,894 | 0 | 22,894 | 0 to 22.9 K |
Feb 17 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 31.71 | 16,250 | 515,288 | 48,750 | |
Feb 17 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 65.29 | 9,528 | 622,083 | 0 | 9.5 K to 0 (-100.00 %) |
Feb 17 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 64.59 | 1,700 | 109,803 | 9,528 | 11.2 K to 9.5 K (-15.14 %) |
Feb 17 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 63.42 | 5,022 | 318,495 | 11,228 | 16.3 K to 11.2 K (-30.90 %) |
Feb 17 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 31.71 | 16,250 | 515,288 | 16,250 | 0 to 16.3 K |
Feb 03 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 7.27 | 1,562 | 11,356 | 35,938 | |
Feb 03 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,604 | 17,056 | 52,084 | |
Feb 03 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,604 | 17,056 | 23,438 | |
Feb 03 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 56.41 | 300 | 16,923 | 0 | 300 to 0 (-100.00 %) |
Feb 03 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 55.61 | 6,470 | 359,797 | 300 | 6.8 K to 300 (-95.57 %) |
Feb 03 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 7.27 | 1,562 | 11,356 | 6,770 | 5.2 K to 6.8 K (+29.99 %) |
Feb 03 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,604 | 17,056 | 5,208 | 2.6 K to 5.2 K (+100.00 %) |
Feb 03 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,604 | 17,056 | 2,604 | 0 to 2.6 K |
Jan 20 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.27 | 417 | 2,615 | 1,250 | |
Jan 20 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 69.00 | 417 | 28,773 | 0 | 417 to 0 (-100.00 %) |
Jan 20 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.27 | 417 | 2,615 | 417 | 0 to 417 |
Jan 06 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 7.27 | 1,563 | 11,363 | 37,500 | |
Jan 06 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,604 | 17,056 | 54,688 | |
Jan 06 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,604 | 17,056 | 26,042 | |
Jan 06 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 59.46 | 267 | 15,876 | 0 | 267 to 0 (-100.00 %) |
Jan 06 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 58.63 | 495 | 29,022 | 267 | 762 to 267 (-64.96 %) |
Jan 06 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 57.82 | 3,800 | 219,716 | 762 | 4.6 K to 762 (-83.30 %) |
Jan 06 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 56.12 | 2,209 | 123,969 | 4,562 | 6.8 K to 4.6 K (-32.62 %) |
Jan 06 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 7.27 | 1,563 | 11,363 | 6,771 | 5.2 K to 6.8 K (+30.01 %) |
Jan 06 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,604 | 17,056 | 5,208 | 2.6 K to 5.2 K (+100.00 %) |
Jan 06 2021 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,604 | 17,056 | 2,604 | 0 to 2.6 K |
Dec 23 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.27 | 417 | 2,615 | 1,667 | |
Dec 23 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 59.14 | 417 | 24,661 | 0 | 417 to 0 (-100.00 %) |
Dec 23 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.27 | 417 | 2,615 | 417 | 0 to 417 |
Dec 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 7.27 | 1,562 | 11,356 | 39,063 | |
Dec 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,604 | 17,056 | 57,292 | |
Dec 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,604 | 17,056 | 28,646 | |
Dec 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 49.43 | 3,693 | 182,545 | 0 | 3.7 K to 0 (-100.00 %) |
Dec 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 48.20 | 3,077 | 148,311 | 3,693 | 6.8 K to 3.7 K (-45.45 %) |
Dec 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 7.27 | 1,562 | 11,356 | 6,770 | 5.2 K to 6.8 K (+29.99 %) |
Dec 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,604 | 17,056 | 5,208 | 2.6 K to 5.2 K (+100.00 %) |
Dec 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,604 | 17,056 | 2,604 | 0 to 2.6 K |
Nov 23 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.27 | 416 | 2,608 | 2,084 | |
Nov 23 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 48.86 | 416 | 20,326 | 0 | 416 to 0 (-100.00 %) |
Nov 23 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.27 | 416 | 2,608 | 416 | 0 to 416 |
Nov 04 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 7.27 | 1,563 | 11,363 | 40,625 | |
Nov 04 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,604 | 17,056 | 59,896 | |
Nov 04 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,605 | 17,063 | 31,250 | |
Nov 04 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 46.14 | 1,074 | 49,554 | 0 | 1.1 K to 0 (-100.00 %) |
Nov 04 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 45.47 | 5,698 | 259,088 | 1,074 | 6.8 K to 1.1 K (-84.14 %) |
Nov 04 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 7.27 | 1,563 | 11,363 | 6,772 | 5.2 K to 6.8 K (+30.01 %) |
Nov 04 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,604 | 17,056 | 5,209 | 2.6 K to 5.2 K (+99.96 %) |
Nov 04 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,605 | 17,063 | 2,605 | 0 to 2.6 K |
Oct 20 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.27 | 417 | 2,615 | 2,500 | |
Oct 20 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 51.25 | 417 | 21,371 | 0 | 417 to 0 (-100.00 %) |
Oct 20 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.27 | 417 | 2,615 | 417 | 0 to 417 |
Oct 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 7.27 | 1,562 | 11,356 | 42,188 | |
Oct 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,605 | 17,063 | 62,500 | |
Oct 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,604 | 17,056 | 33,855 | |
Oct 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 49.26 | 893 | 43,989 | 0 | 893 to 0 (-100.00 %) |
Oct 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 48.46 | 5,878 | 284,848 | 893 | 6.8 K to 893 (-86.81 %) |
Oct 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 7.27 | 1,562 | 11,356 | 6,771 | 5.2 K to 6.8 K (+29.99 %) |
Oct 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,605 | 17,063 | 5,209 | 2.6 K to 5.2 K (+100.04 %) |
Oct 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,604 | 17,056 | 2,604 | 0 to 2.6 K |
Sep 23 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.27 | 417 | 2,615 | 2,917 | |
Sep 23 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 45.51 | 417 | 18,978 | 0 | 417 to 0 (-100.00 %) |
Sep 23 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.27 | 417 | 2,615 | 417 | 0 to 417 |
Sep 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 7.27 | 1,563 | 11,363 | 43,750 | |
Sep 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,604 | 17,056 | 65,105 | |
Sep 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,604 | 17,056 | 36,459 | |
Sep 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 41.75 | 300 | 12,525 | 0 | 300 to 0 (-100.00 %) |
Sep 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 41.28 | 6,471 | 267,123 | 300 | 6.8 K to 300 (-95.57 %) |
Sep 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 7.27 | 1,563 | 11,363 | 6,771 | 5.2 K to 6.8 K (+30.01 %) |
Sep 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,604 | 17,056 | 5,208 | 2.6 K to 5.2 K (+100.00 %) |
Sep 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,604 | 17,056 | 2,604 | 0 to 2.6 K |
Aug 19 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.27 | 416 | 2,608 | 3,334 | |
Aug 19 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 41.57 | 416 | 17,293 | 0 | 416 to 0 (-100.00 %) |
Aug 19 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.27 | 416 | 2,608 | 416 | 0 to 416 |
Aug 05 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.32 | 417 | 2,635 | 0 | |
Aug 05 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 7.27 | 1,562 | 11,356 | 45,313 | |
Aug 05 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,604 | 17,056 | 67,709 | |
Aug 05 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,604 | 17,056 | 39,063 | |
Aug 05 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 40.00 | 7,187 | 287,480 | 0 | 7.2 K to 0 (-100.00 %) |
Aug 05 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.32 | 417 | 2,635 | 7,187 | 6.8 K to 7.2 K (+6.16 %) |
Aug 05 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 7.27 | 1,562 | 11,356 | 6,770 | 5.2 K to 6.8 K (+29.99 %) |
Aug 05 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,604 | 17,056 | 5,208 | 2.6 K to 5.2 K (+100.00 %) |
Aug 05 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,604 | 17,056 | 2,604 | 0 to 2.6 K |
Jul 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.27 | 417 | 2,615 | 3,750 | |
Jul 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 40.00 | 417 | 16,680 | 0 | 417 to 0 (-100.00 %) |
Jul 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.27 | 417 | 2,615 | 417 | 0 to 417 |
Jul 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 7.27 | 1,563 | 11,363 | 46,875 | |
Jul 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,604 | 17,056 | 70,313 | |
Jul 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,604 | 17,056 | 41,667 | |
Jul 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 48.13 | 1,200 | 57,756 | 0 | 1.2 K to 0 (-100.00 %) |
Jul 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 47.17 | 5,571 | 262,784 | 1,200 | 6.8 K to 1.2 K (-82.28 %) |
Jul 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 7.27 | 1,563 | 11,363 | 6,771 | 5.2 K to 6.8 K (+30.01 %) |
Jul 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,604 | 17,056 | 5,208 | 2.6 K to 5.2 K (+100.00 %) |
Jul 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,604 | 17,056 | 2,604 | 0 to 2.6 K |
Jul 01 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.32 | 417 | 2,635 | 417 | |
Jul 01 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 47.42 | 417 | 19,774 | 0 | 417 to 0 (-100.00 %) |
Jul 01 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.32 | 417 | 2,635 | 417 | 0 to 417 |
Jun 30 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.32 | 417 | 2,635 | 417 | |
Jun 30 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 47.42 | 417 | 19,774 | 0 | 417 to 0 (-100.00 %) |
Jun 30 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.32 | 417 | 2,635 | 417 | 0 to 417 |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.27 | 417 | 2,615 | 4,167 | |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 45.00 | 417 | 18,765 | 0 | 417 to 0 (-100.00 %) |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.27 | 417 | 2,615 | 417 | 0 to 417 |
Jun 05 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 7.27 | 1,562 | 11,356 | 48,438 | |
Jun 05 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,604 | 17,056 | 72,917 | |
Jun 05 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,604 | 17,056 | 43,271 | |
Jun 05 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 40.00 | 6,770 | 270,800 | 0 | 6.8 K to 0 (-100.00 %) |
Jun 05 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 7.27 | 1,562 | 11,356 | 6,770 | 5.2 K to 6.8 K (+29.99 %) |
Jun 05 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,604 | 17,056 | 5,208 | 2.6 K to 5.2 K (+100.00 %) |
Jun 05 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,604 | 17,056 | 2,604 | 0 to 2.6 K |
May 28 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.32 | 416 | 2,629 | 834 | |
May 28 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 42.00 | 416 | 17,472 | 0 | 416 to 0 (-100.00 %) |
May 28 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.32 | 416 | 2,629 | 416 | 0 to 416 |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 7.27 | 25,000 | 181,750 | 50,000 | |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 49,479 | 324,087 | 75,521 | |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 78,125 | 511,719 | 45,875 | |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.27 | 15,416 | 96,658 | 4,584 | |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.32 | 18,750 | 118,500 | 1,250 | |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 1.98 | 60,000 | 118,800 | 0 | |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 40.00 | 246,770 | 9,870,800 | 0 | 246.8 K to 0 (-100.00 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 7.27 | 25,000 | 181,750 | 246,770 | 221.8 K to 246.8 K (+11.27 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 49,479 | 324,087 | 221,770 | 172.3 K to 221.8 K (+28.72 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 78,125 | 511,719 | 172,291 | 94.2 K to 172.3 K (+82.97 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.27 | 15,416 | 96,658 | 94,166 | 78.8 K to 94.2 K (+19.58 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.32 | 18,750 | 118,500 | 78,750 | 60 K to 78.8 K (+31.25 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 1.98 | 60,000 | 118,800 | 60,000 | 0 to 60 K |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 7.27 | 25,000 | 181,750 | 50,000 | |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 49,479 | 324,087 | 75,521 | |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 78,125 | 511,719 | 45,875 | |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.27 | 15,416 | 96,658 | 4,584 | |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.32 | 18,750 | 118,500 | 1,250 | |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 1.98 | 60,000 | 118,800 | 0 | |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 40.00 | 246,770 | 9,870,800 | 0 | 246.8 K to 0 (-100.00 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 7.27 | 25,000 | 181,750 | 246,770 | 221.8 K to 246.8 K (+11.27 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 49,479 | 324,087 | 221,770 | 172.3 K to 221.8 K (+28.72 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 78,125 | 511,719 | 172,291 | 94.2 K to 172.3 K (+82.97 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.27 | 15,416 | 96,658 | 94,166 | 78.8 K to 94.2 K (+19.58 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.32 | 18,750 | 118,500 | 78,750 | 60 K to 78.8 K (+31.25 %) |
May 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 1.98 | 60,000 | 118,800 | 60,000 | 0 to 60 K |
Feb 18 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | SVP, Drug Discovery | Option Exercise | A | 31.71 | 65,000 | 2,061,150 | 65,000 |
Page: 1